As a result, NFE2L2 has become a key target in cancer research, with ongoing efforts to develop activators for conditions requiring enhanced oxidative defense, such as neurodegenerative diseases, and inhibitors to counteract its role in tumor resistance and poor prognosis[8]. Here, NFE2L2 is linked to neoplasm.